CLINICAL_TRIALS
trial_result
· 2015-02-10
Clinical Trial Update: Study A - MK0767 Monotherapy Study [Phase 3]
Summary
A Phase 3 monotherapy study of MK0767 for type 2 diabetes mellitus has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED